Mandatory Rest Period

MBP8298 moving along for those that are SPMS

2007-02-28 15:10:36

The first phase of testing
is done and now those patients on placebo can carry on with the actual drug.
I wonder what that feels like when you find out you were on the placebo? Anyone
have that experience? Were you convinced you were actually on the drug? "Eligible
patients who have successfully completed the blinded, placebo controlled MAESTRO-01
trial may choose to receive MBP8298 on an un-blinded basis in MAESTRO-02 regardless
of whether they were previously on placebo or drug. The trial will primarily
evaluate the long-term safety of MBP8298. "Now that the first patients
who participated in our MAESTRO-01 pivotal trial have completed the study, we
are pleased to offer MBP8298 on an open-label basis," said Kevin Giese, President
and CEO of BioMS Medical. "We believe MBP8298 has the potential to become the
only safe and effective first line therapy for the treatment of secondary progressive
MS. While MAESTRO-01 was designed to evaluate the safety and efficacy of MBP8298,
MAESTRO-02 will provide additional important long-term safety and efficacy data
to support regulatory submissions."

- posted by Anonymous @ 9:19 PM - Link @ 9:19 PM - Link to this post - Comments (0)

			Hi, I’m Kim! This site provides a little insight to my journey of being diagnosised with Remitting Relapsing Multiple Sclerosis on October 26th 2004. I review books and documentaries, post MS-related news, and share my photos. Subscribe (RSS) My bloglines Archives Current November 2004 December 2004 January 2005 February 2005 March 2005 April 2005 May 2005 June 2005 July 2005 August 2005 September 2005 October 2005 November 2005 December 2005 January 2006 February 2006 March 2006 April 2006 May 2006 June 2006 July 2006 August 2006 September 2006 October 2006 November 2006 December 2006 January 2007 February 2007 March 2007 April 2007 May 2007 June 2007 July 2007 August 2007 September 2007 October 2007 November 2007 December 2007 January 2008 February 2008 March 2008 April 2008 May 2008 June 2008 July 2008 August 2008 September 2008 October 2008 November 2008 December 2008 January 2009 February 2009 March 2009 April 2009 May 2009 June 2009 July 2009 August 2009 September 2009 October 2009 November 2009 December 2009 January 2010 February 2010 March 2010 May 2010 June 2010 July 2010 September 2010 November 2011

	Wednesday, February 28, 2007 MBP8298 moving along for those that are SPMS 2007-02-28 15:10:36 The first phase of testing is done and now those patients on placebo can carry on with the actual drug. I wonder what that feels like when you find out you were on the placebo? Anyone have that experience? Were you convinced you were actually on the drug? "Eligible patients who have successfully completed the blinded, placebo controlled MAESTRO-01 trial may choose to receive MBP8298 on an un-blinded basis in MAESTRO-02 regardless of whether they were previously on placebo or drug. The trial will primarily evaluate the long-term safety of MBP8298. "Now that the first patients who participated in our MAESTRO-01 pivotal trial have completed the study, we are pleased to offer MBP8298 on an open-label basis," said Kevin Giese, President and CEO of BioMS Medical. "We believe MBP8298 has the potential to become the only safe and effective first line therapy for the treatment of secondary progressive MS. While MAESTRO-01 was designed to evaluate the safety and efficacy of MBP8298, MAESTRO-02 will provide additional important long-term safety and efficacy data to support regulatory submissions." - posted by Anonymous @ 9:19 PM - Link @ 9:19 PM - Link to this post - Comments (0)